DE3772460D1 - PHARMACEUTICAL PREPARATION FOR A PARENTERAL ADMINISTRATION CONTAINING CALCITONIN AS AN ACTIVE SUBSTANCE. - Google Patents

PHARMACEUTICAL PREPARATION FOR A PARENTERAL ADMINISTRATION CONTAINING CALCITONIN AS AN ACTIVE SUBSTANCE.

Info

Publication number
DE3772460D1
DE3772460D1 DE8787108063T DE3772460T DE3772460D1 DE 3772460 D1 DE3772460 D1 DE 3772460D1 DE 8787108063 T DE8787108063 T DE 8787108063T DE 3772460 T DE3772460 T DE 3772460T DE 3772460 D1 DE3772460 D1 DE 3772460D1
Authority
DE
Germany
Prior art keywords
parenteral administration
active substance
pharmaceutical preparation
administration containing
containing calcitonin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787108063T
Other languages
German (de)
Inventor
Filippo Lattanzi
Riccardo Vanni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sclavo SpA
Original Assignee
Sclavo SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sclavo SpA filed Critical Sclavo SpA
Application granted granted Critical
Publication of DE3772460D1 publication Critical patent/DE3772460D1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Abstract

A new freeze-dried pharmaceutical composition for parenteral administration, which comprises a therapeutically effective amount of a calcitonin, as the active ingredient, and human albumin. The injectable solution which is obtained by dissolving the freeze-dried composition in a physiologically acceptable solvent is also described.
DE8787108063T 1986-06-20 1987-06-04 PHARMACEUTICAL PREPARATION FOR A PARENTERAL ADMINISTRATION CONTAINING CALCITONIN AS AN ACTIVE SUBSTANCE. Expired - Fee Related DE3772460D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20865/86A IT1204400B (en) 1986-06-20 1986-06-20 PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN

Publications (1)

Publication Number Publication Date
DE3772460D1 true DE3772460D1 (en) 1991-10-02

Family

ID=11173243

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787108063T Expired - Fee Related DE3772460D1 (en) 1986-06-20 1987-06-04 PHARMACEUTICAL PREPARATION FOR A PARENTERAL ADMINISTRATION CONTAINING CALCITONIN AS AN ACTIVE SUBSTANCE.

Country Status (9)

Country Link
US (1) US5310727A (en)
EP (1) EP0249811B1 (en)
JP (1) JPS635028A (en)
AT (1) ATE66615T1 (en)
CA (1) CA1289071C (en)
DE (1) DE3772460D1 (en)
ES (1) ES2051709T3 (en)
GR (1) GR3002765T3 (en)
IT (1) IT1204400B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2514249B2 (en) * 1989-05-23 1996-07-10 帝人株式会社 Stabilized calcitonin pharmaceutical composition
JPH078804B2 (en) * 1990-08-28 1995-02-01 三菱化学株式会社 Preparations containing corticotropin-releasing factor
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
JPH0827018A (en) * 1994-07-22 1996-01-30 Sanwa Kagaku Kenkyusho Co Ltd Medicinal composition containing physiologically active peptide or protein
IT1282374B1 (en) * 1996-01-31 1998-03-20 Therapicon Srl PARENTERAL PHARMACEUTICAL COMPOSITIONS BASED ON PH CONTROLLED SYNTHETIC CALCITONINS WITH LOW PAIN INDEX
US5912014A (en) * 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
WO2001056594A1 (en) 2000-02-04 2001-08-09 Unigene Laboratories, Inc. Nasal calcitonin formulations
EP1832599A3 (en) * 2000-04-12 2007-11-21 Human Genome Sciences, Inc. Albumin fusion proteins
US8088734B2 (en) * 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
US10342239B2 (en) * 2017-03-31 2019-07-09 George Pul Filled dough producing apparatus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32347E (en) * 1972-05-15 1987-02-03 Ciba-Geigy Corp. Hypocalcaemic peptides and process for their manufacture
US4241051A (en) * 1977-11-04 1980-12-23 Christie Robert B Calcitonin
US4338335A (en) * 1980-02-05 1982-07-06 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
JPS59163313A (en) * 1983-03-09 1984-09-14 Teijin Ltd Peptide hormone composition for nasal administration
US4514331A (en) * 1983-06-29 1985-04-30 University Patents, Inc. Peptide hormones with calcitonin-like activity
JPS60193925A (en) * 1984-03-13 1985-10-02 Chemo Sero Therapeut Res Inst Lyophilized pharmaceutical preparation vaccine

Also Published As

Publication number Publication date
CA1289071C (en) 1991-09-17
GR3002765T3 (en) 1993-01-25
IT8620865A0 (en) 1986-06-20
ES2051709T3 (en) 1994-07-01
IT1204400B (en) 1989-03-01
ATE66615T1 (en) 1991-09-15
EP0249811A1 (en) 1987-12-23
JPS635028A (en) 1988-01-11
EP0249811B1 (en) 1991-08-28
US5310727A (en) 1994-05-10

Similar Documents

Publication Publication Date Title
ES2069582T3 (en) THERAPEUTIC NUCLEOSIDES.
CA2093806A1 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
DK395689A (en) PHARMACEUTICAL PREPARATION FOR TREATMENT OF DIABETES MELLITUS
DE69233413D1 (en) Pharmaceutical composition containing a physiologically active polypeptide
NO842290L (en) PROCEDURE FOR THE PREPARATION OF PREPARATIONS CONTAINING ORAL ANTIDIABETIC ACTIVE SUBSTANCES
ES2051920T3 (en) A PHARMACEUTICAL COMPOSITION AND ITS PREPARATION PROCEDURE.
ATE76747T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING LEVODOPA METHYL ESTER, THEIR PREPARATION AND THERAPEUTIC USES.
NO168629C (en) PROCEDURE FOR THE PREPARATION OF ORAL ADMINISTRATIVE, ANTIDIABETIC EFFECTIVE PREPARATIONS
NO174412C (en) Process for preparing a programmed release pharmaceutical formulation for oral use
BR9401199A (en) Drug preparations, process for the preparation of a medicine preparation, process for the preparation of a medicine formulation.
ATE66615T1 (en) PHARMACEUTICAL PREPARATION FOR PARENTERAL ADMINISTRATION, CONTAINING CALCITONIN AS AN ACTIVE SUBSTANCE.
DE3875108D1 (en) PHYSIOLOGICALLY ACTIVE POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION.
BE1000722A4 (en) PHARMACEUTICAL COMPOSITIONS OF POLYPEPTIDES ADAPTED TO GASTROINTESTINAL RESORPTION.
MC2025A1 (en) MEDICINAL PRODUCT CONTAINING AZELASTINE AND CAPABLE OF RELEASING IT IN A CONTROLLED WAY
NO901128L (en) PROCEDURE FOR THE PREPARATION OF A TRANSDERMAL THERAPEUTIC SYSTEM WITH STEP INGREDIENT RELEASE AND APPLICATION FOR LOCAL OR SYSTEMIC INGREDIENT ADMINISTRATION.
JPS5576816A (en) Drug for medicinal fatty liver
ATE80036T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING AN 8-CHLORO-BENZOTHIAZEPINE COMPOUND AND ITS USE.
ES512748A0 (en) "PROCEDURE FOR THE PREPARATION OF TABLETS BASED ON THE ANTIBIOTIC PHOSPHOMYCIN".
DK493887A (en) BUCCAL FORMULATION
DK0560207T3 (en) Preparation for oral use based on ibuprofen
ITRM910038A1 (en) PHARMACEUTICAL COMPOSITIONS HAVING CALCITONIN AS AN ACTIVE SUBSTANCE TO BE ADMINISTERED INTRANASALLY.
RU94001686A (en) IMMUNOMODULATIVE MEDICINE

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee